Business Context and Reporting Period
Trulieve Cannabis Corp. filed a Form 8-K dated January 28, 2022, reporting the issuance of additional senior secured debt and related Regulation FD disclosure. The filing does not provide quarterly or annual operating results.
Key Financial Metrics and Capital Structure
| Item | Reported detail |
|---|---|
| Additional debt issued | $75 million aggregate principal amount |
| Interest rate | 8.0% per annum, payable semi-annually on April 6 and October 6 |
| Total outstanding notes after issuance | $425 million aggregate principal amount |
| Maturity | October 6, 2026, unless earlier redeemed or repurchased |
| Issue price | $1,000 per $1,000 principal amount plus $24.9863 of accrued but unpaid interest per $1,000 |
| Intended use of proceeds | Capital expenditures and other general corporate purposes |
| Guarantees | Joint and several guarantees by restricted subsidiaries; Trulieve, Inc. was the only restricted subsidiary as of January 28, 2022 |
The filing does not provide revenue, profit, cash flow, operating margin, liquidity balances, or debt-to-equity and leverage ratios.
Material Changes Versus the Prior Comparable Period
- The company increased its outstanding 8.0% senior secured notes due 2026 from $350 million to $425 million through the issuance of $75 million of additional notes.
- The additional notes have terms identical to the original 2026 notes other than the issue price and accrued-interest component.
- The notes rank pari passu with the company’s outstanding senior secured notes due 2024 and senior to existing and future unsecured indebtedness, subject to the stated legal-priority limitations.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- No operating or financial guidance is provided in the filing.
- The notes are secured by a general security interest in company assets, excluding shares of unrestricted subsidiaries, and pledges of shares of certain restricted subsidiaries.
- The indenture restricts dividends and other restricted payments, investments, asset sales, additional indebtedness, liens, affiliate transactions, material-permit dispositions, and certain mergers or asset transfers.
- Holders may require the company to repurchase notes following a change of control at 101% of principal, plus accrued and unpaid interest.
- Optional redemption premiums range from 104% to 100% for redemptions beginning October 6, 2023; up to 35% of the notes may be redeemed before that date using concurrent equity-issuance proceeds at 108%, subject to the indenture.
- Certain events of default allow the trustee or holders of at least 51% of the outstanding principal amount to accelerate the notes.
- The notes were sold in a private placement relying on an exemption from Securities Act registration and are not registered securities.
Important Facts for Investors to Verify
- Confirm the company’s post-issuance total debt, including the 2024 notes and any other obligations not described in this filing.
- Assess whether capital expenditures and general corporate uses of the proceeds are consistent with management’s broader strategy and liquidity needs.
- Review the full base indenture, supplemental indenture, collateral package, covenants, permitted-debt baskets, and events of default.
- Verify the company’s cash balance, debt-service capacity, interest expense, and compliance with applicable covenants in subsequent financial filings.
- Evaluate refinancing and maturity risk associated with the October 2026 maturity and the company’s secured-debt obligations.